4.7 Article

The cleaved-Caspase-3 antibody is a marker of Caspase-9-like DRONC activity in Drosophila

Journal

CELL DEATH AND DIFFERENTIATION
Volume 17, Issue 3, Pages 534-539

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/cdd.2009.185

Keywords

cleaved-Caspase-3; Drosophila; DRICE; DRONC; Dcp-1

Funding

  1. NIH [GM068016, GM081543, GM074977]
  2. Welch Foundation [G-1496]

Ask authors/readers for more resources

The cleaved-Caspase-3 antibody is a popular tool in apoptosis research in Drosophila. As the antibody was raised against cleaved human Caspase-3, it was assumed that it detects cleaved DRICE and DCP-1, Caspase-3-like effector caspases in Drosophila. However, as shown here, strong immunoreactivity persists in apoptotic models doubly mutant for drICE and dcp-1. In contrast, mutants of the apoptosome components DRONC (Caspase-9-like) and ARK (Apaf-1 related) do not label with the cleaved-Caspase-3 antibody. By peptide blocking experiments and further genetic studies, we provide evidence that the cleaved-Caspase-3 antibody recognizes multiple proteins including DCP-1 and likely DRICE, but also at least one additional unknown protein, all of which require DRONC for epitope exposure. The unknown substrate may be involved in non-apoptotic functions of DRONC. Because the cleaved-Caspase-3 antibody not only detects cleaved Caspase-3-like proteins in Drosophila, but also other proteins in a DRONC-dependent manner, it is more accurate to consider the cleaved-Caspase-3 antibody as a marker for DRONC activity, rather than effector caspase activity. Cell Death and Differentiation (2010) 17, 534-539; doi: 10.1038/cdd.2009.185; published online 4 December 2009

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available